National Multicenter Trial Evaluating Two Treatments in Patients With Primary Human Immunodeficiency Virus (HIV-1) Infection
- Conditions
- Interventions
- First Posted Date
- 2016-12-09
- Last Posted Date
- 2022-01-04
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 101
- Registration Number
- NCT02987530
An HIV Vaccine Trial in Individuals Who Started ART During Primary or Chronic Infection
- First Posted Date
- 2016-11-23
- Last Posted Date
- 2019-08-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 1
- Registration Number
- NCT02972450
- Locations
- 🇨🇭
CHUV, Lausanne, Switzerland
🇬🇧Chelsea & Westminster Hospital, London, United Kingdom
Tenofovir As Prevention Of Hepatitis b Mother-to-child Transmission
- Conditions
- Interventions
- First Posted Date
- 2016-10-19
- Last Posted Date
- 2019-10-16
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 933
- Registration Number
- NCT02937779
- Locations
- 🇰🇭
Kampong Cham Provincial Hospital, Kampong Cham, Cambodia
🇰🇭Calmette Hospital, Phnom Penh, Cambodia
🇰🇭National Mother and Child Health Center, Phnom Penh, Cambodia
Gut-Associated Lymphocyte Trafficking
- Conditions
- Interventions
- First Posted Date
- 2016-09-19
- Last Posted Date
- 2022-01-14
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 80
- Registration Number
- NCT02906137
- Locations
- 🇫🇷
Hôpital Purpan - Service de Médecine Interne, Toulouse, France
🇫🇷Hôpital Purpan - Service des maladies Infectieuses, Toulouse, France
Co-adaptation Between Human Immunodeficiency Virus (HIV) and Cluster of Differentiation 8 (CD8) Cellular Immunity
- Conditions
- First Posted Date
- 2016-09-01
- Last Posted Date
- 2018-09-28
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 22
- Registration Number
- NCT02886416
Investigative Mathematical Modeling of Hospital Transmission of Hepatitis C
- Conditions
- First Posted Date
- 2016-07-11
- Last Posted Date
- 2017-04-10
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 550
- Registration Number
- NCT02826447
- Locations
- 🇪🇬
Ain Shams University Teaching Hospital, Cairo, Egypt
Efficacy and Safety of a Dolutegravir-based Regimen for the Initial Management of HIV Infected Adults in Resource-limited Settings
- Conditions
- Interventions
- First Posted Date
- 2016-05-19
- Last Posted Date
- 2021-08-31
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 616
- Registration Number
- NCT02777229
- Locations
- 🇨🇲
Military Hospital, Yaoundé, Cameroon
🇨🇲Hopital Central, Yaoundé, Cameroon
🇨🇲Cité verte Hospital, Yaoundé, Cameroon
Prevention of Perinatal Transmission of HIV-1 Without Nucleoside Reverse Transcriptase Inhibitors
- Conditions
- Interventions
- First Posted Date
- 2016-04-14
- Last Posted Date
- 2021-08-06
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 91
- Registration Number
- NCT02738502
- Locations
- 🇫🇷
Hôpital Saint André, Bordeaux, France
🇫🇷Hôpital Louis Mourier, Colombes, France
🇫🇷Hôpital Bicêtre, Le Kremlin Bicêtre, France
CLEAC (Comparison of Late Versus Early Antiretroviral Therapy in HIV-infected Children)
- First Posted Date
- 2016-02-05
- Last Posted Date
- 2019-01-18
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 80
- Registration Number
- NCT02674867
- Locations
- 🇫🇷
Hôpital Jean Verdier, Bondy, France
🇫🇷Hôpital Louis Mourier, Colombes, France
🇫🇷Centre Hospitalier Intercommunal, Créteil, France
Study to Assess Efficacy and Safety of Grazoprevir/Elbasvir Associated With Sofosbuvir and Ribavirin in HCV Genotype 1 or 4-infected Patients Who Failed Direct Acting Antivirals (DAA) Bitherapy With Sofosbuvir
- Conditions
- Interventions
- First Posted Date
- 2016-01-06
- Last Posted Date
- 2017-06-29
- Lead Sponsor
- ANRS, Emerging Infectious Diseases
- Target Recruit Count
- 26
- Registration Number
- NCT02647632